Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) saw a significant decrease in short interest in April. As of April 30th, there was short interest totalling 1,300 shares, a decrease of 55.2% from the April 15th total of 2,900 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 18,500 […]
StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a report released on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $10.00 target price on shares of Pulmatrix in a report on Tuesday, February 7th. Pulmatrix Trading Up […]
StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a report issued on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $10.00 price target on shares of Pulmatrix in a research report on Tuesday, February 7th. Pulmatrix […]
Pulmatrix, Inc. (NASDAQ:PULM – Get Rating) was the recipient of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 2,900 shares, a decrease of 64.2% from the March 15th total of 8,100 shares. Approximately 0.1% of the company’s shares are sold short. Based on […]
StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a report released on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $10.00 target price on shares of Pulmatrix in a research report on Tuesday, February 7th. Pulmatrix […]